<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase I:  Multi-Thickness Mode Harmonic Array</AwardTitle>
<AwardEffectiveDate>01/01/2008</AwardEffectiveDate>
<AwardExpirationDate>11/30/2008</AwardExpirationDate>
<AwardTotalIntnAmount>0.00</AwardTotalIntnAmount>
<AwardAmount>100000</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Cheryl F. Albus</SignBlockName>
</ProgramOfficer>
<AbstractNarration>This Small Business Innovation Research (SBIR) Phase I project will design and develop a very broadband and high sensitivity probe via the use of multi-thickness mode single crystal ferroelectrics; having superior electromechanical coupling coefficient. The unique design of the proposed array probe will produce the required two-octave bandwidth for operating at the subharmonic, first harmonic and second harmonic frequencies. In this project, the first harmonic transmit/receive frequency will be 4.0 MHz with corresponding subharmonic and second harmonic echoes at 2.0 MHz and 8.0 MHz, respectively. This project will develop a single crystal linear array with multi-resonance frequencies. A 16-element array will be fabricated, utilizing the "dice and fill" method that is ideally suited for the frequency regime common to medical imaging (1-10 MHz). Feasibility will be demonstrated with measurement of the temporal and spectral scattered echo returns from a fluid with microbubble-based ultrasound contrast agent.&lt;br/&gt;&lt;br/&gt;The broader impact/commercial potential if successful, will be a significant advancement of numerous clinical applications, such as the enhanced detection of myocardial perfusion, perfusion abnormalities of kidney parenchyma, and liver tumors. The long-term goal is to develop a single probe amenable for several diagnostic studies: adult and pediatric abdominal, breast, peripheral vascular, small parts, musculoskeletal, and cardiac (sub-sternum).</AbstractNarration>
<MinAmdLetterDate>11/07/2007</MinAmdLetterDate>
<MaxAmdLetterDate>06/05/2008</MaxAmdLetterDate>
<ARRAAmount/>
<AwardID>0740464</AwardID>
<Investigator>
<FirstName>Bahram</FirstName>
<LastName>Jadidian</LastName>
<EmailAddress>b.jadidian@jwmed.com</EmailAddress>
<StartDate>11/07/2007</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>J&amp;W Medical LLC</Name>
<CityName>Westport</CityName>
<ZipCode>068801921</ZipCode>
<PhoneNumber>2032260810</PhoneNumber>
<StreetAddress>56 Partrick Rd.</StreetAddress>
<CountryName>United States</CountryName>
<StateName>Connecticut</StateName>
<StateCode>CT</StateCode>
</Institution>
<FoaInformation>
<Code>0308000</Code>
<Name>Industrial Technology</Name>
</FoaInformation>
<ProgramElement>
<Code>5371</Code>
<Text>SBIR Phase I</Text>
</ProgramElement>
<ProgramReference>
<Code>1491</Code>
<Text>BIOTECH, BIOCHEM &amp; BIOMASS ENG</Text>
</ProgramReference>
<ProgramReference>
<Code>9163</Code>
<Text>SINGLE DIVISION/UNIVERSITY - INDUSTRY</Text>
</ProgramReference>
<ProgramReference>
<Code>AMPP</Code>
<Text>ADVANCED MATERIALS &amp; PROCESSING PROGRAM</Text>
</ProgramReference>
</Award>
</rootTag>
